Lercanidipine hydrochloride hemihydrate, >=98% (HPLC), powder

Lercanidipine hydrochloride hemihydrate, >=98% (HPLC), powder

Biochem/physiol Actions

Lercanidipine hydrochloride is a L-type (Cav1.2b) vascular channel antagonist; L-type (Cav1.2a) cardiac channel agonist voltage-dependent and highly lipophylic compound, which exhibits a slower onset and longer duration of action than other calcium channel antagonists; an antihypertensive agent in patients with mild-to-moderate hypertension; more vasoselective than lacidipine and amlodipine.

Features and Benefits

This compound was developed by Forest Labs. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573443 Lercanidipine hydrochloride hemihydrate, >=98% (HPLC), powder yellow 100 WMFYOYKPJLRMJI-UHFFFAOYSA-N 1S/C36H41N3O6.ClH/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27;/h SIGMA-ALDRICH powder ≥98% (HPLC)
£270.21 (exc VAT) per 10MG
-
+
3573444 Lercanidipine hydrochloride hemihydrate, >=98% (HPLC), powder yellow 100 WMFYOYKPJLRMJI-UHFFFAOYSA-N 1S/C36H41N3O6.ClH/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27;/h SIGMA-ALDRICH powder ≥98% (HPLC)
£743.79 (exc VAT) per 50MG
-
+